PLUR

Pluri Inc. PLUR

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode PLUR ANTX QTTB NXTC IBIO BOLD PSTV ITRM INTS SABS
6M -12.37 % 4.55 % 93.48 % 103.72 % 155.19 % 19.23 % 195.82 % -61.61 % 48.01 % 122.63 %
YTD -19.86 % -17.27 % -13.07 % 16.53 % -18.80 % -54.58 % -51.36 % -79.23 % -76.57 % 7.41 %
1Y -21.14 % -9.45 % -10.21 % 0.79 % -18.80 % -50.79 % -42.03 % -78.28 % -79.50 % 2.18 %
3Y -55.28 % -88.27 % -87.18 % -25.78 % -75.44 % 12 399 900.00 % -87.66 % -61.91 % -93.12 % -50.81 %
5Y -92.98 % -92.53 % -98.70 % -90.79 % -99.68 % 12 399 900.00 % -98.21 % -97.41 % -93.12 % -96.07 %
10Y -96.20 % -92.53 % -99.11 % -95.19 % -99.94 % 12 399 900.00 % -100.00 % -99.80 % -93.12 % -96.07 %
From the beginning -99.98 % -92.53 % -99.11 % -95.19 % -99.96 % 12 399 900.00 % -100.00 % -99.80 % -93.12 % -96.07 %

Dividend

AN2 Therapeutics, Inc.